The ONTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ONTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ONTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ONTX Detailed Price Forecast - CNN Money||View ONTX Detailed Summary - Google Finance|
|View ONTX Detailed Summary - Yahoo! Finance||View ONTX Stock Research & Analysis - Zacks.com|
|View ONTX Trends & Analysis - Trade-Ideas||View ONTX Major Holders - Barrons|
|View ONTX Call Transcripts - NASDAQ||View ONTX Breaking News & Analysis - Seeking Alpha|
|View ONTX Annual Report - CompanySpotlight.com||View ONTX OTC Short Report - OTCShortReport.com|
|View ONTX Fundamentals - TradeKing||View ONTX SEC Filings - Bar Chart|
|View Historical Prices for ONTX - The WSJ||View Performance/Total Return for ONTX - Morningstar|
|View the Analyst Estimates for ONTX - MarketWatch||View the Earnings History for ONTX - CNBC|
|View the ONTX Earnings - StockMarketWatch||View ONTX Buy or Sell Recommendations - MacroAxis|
|View the ONTX Bullish Patterns - American Bulls||View ONTX Short Pain Metrics - ShortPainBot.com|
|View ONTX Stock Mentions - StockTwits||View ONTX Stock Mentions - PennyStockTweets|
|View ONTX Stock Mentions - Twitter||View ONTX Investment Forum News - Investor Hub|
|View ONTX Stock Mentions - Yahoo! Message Board||View ONTX Stock Mentions - Seeking Alpha|
|View Insider Transactions for ONTX - SECform4.com||View Insider Transactions for ONTX - Insider Cow|
|View ONTX Major Holdings Summary - CNBC||View Insider Disclosure for ONTX - OTC Markets|
|View Insider Transactions for ONTX - Yahoo! Finance||View Institutional Holdings for ONTX - NASDAQ|
|View ONTX Stock Insight & Charts - FinViz.com||View ONTX Investment Charts - StockCharts.com|
|View ONTX Stock Overview & Charts - BarChart||View ONTX User Generated Charts - Trading View|
Onconova Welcomes Avi Oler, JD, MBA, as Vice President, Corporate Development and General Counsel
Posted on Monday December 10, 2018
Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced that Mr. Abraham “Avi” Oler has joined Onconova’s management team as Vice President, Corporate Development and General Counsel. Mr. Oler will be primarily responsible for business development, investor relations, and legal affairs of the Company. To help further advance Rigosertib, the Company’s Phase 3 candidate for MDS, Mr. Oler’s focus will be on forging new collaborations in additional geographies. Rigosertib is currently partnered with SymBio Pharmaceuticals for Japan and Korea, and with Pint Pharma for Latin America. Information about partnering opportunities can be obtained via e-mail at email@example.com or via the Company’s website: https://www.onconova.com/partnering.
Onconova Highlights Results from Phase 2 Trial of Oral Rigosertib In Combination with Azacitidine (Vidaza®) in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting
Posted on Monday December 03, 2018
Overall response rate (ORR) of 90% reported in this multi-institutional Phase 2 study in hypomethylating agent (HMA) naïve patients, including Complete Remission (CR) rate of.
Edited Transcript of ONTX earnings conference call or presentation 13-Nov-18 2:00pm GMT
Posted on Friday November 16, 2018
Q3 2018 Onconova Therapeutics Inc Earnings Call
Onconova Therapeutics Announces Business Highlights and Financial Results for Third Quarter 2018
Posted on Tuesday November 13, 2018
Conference Call Today at 9:00 a.m. Eastern Time NEWTOWN, Pa., Nov. 13, 2018 -- Onconova Therapeutics, Inc. (Nasdaq: ONTX), a Phase 3 stage biopharmaceutical company focused on.